Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
about
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathyOverexpression of collagen XIII in extraocular fat affected by active thyroid-associated ophthalmopathy: A crucial piece of the puzzle?Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surfaceRisk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.Blood-aqueous barrier integrity in patients with Graves' ophthalmopathy (GO), before and after rehabilitative surgery.Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures.Severe Ophthalmological Complications of Thyroid Disease are Rare in Ibadan, Southwestern Nigeria: Results of a Pilot StudyOptic Neuropathy in Thyroid Eye Disease: A Case SeriesDiagnostic ability of Barrett's index to detect dysthyroid optic neuropathy using multidetector computed tomography.Ocular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease - five new cases and reviewCompressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series.Update on thyroid eye disease and management.Surgical treatment of dysthyroid orbitopathy.Evaluation of the association between subconjunctival orbital fat prolapse and thyroid-associated orbitopathy.Orbital Volumetry in Graves' Orbitopathy: Muscle and Fat Involvement in relation to Dysthyroid Optic Neuropathy.The diagnosis and treatment of thyroid-associated ophthalmopathy.Low dose orbital radiotherapy for thyroid eye disease.Age differences in clinical manifestation and prognosis of thyroid eye disease.Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.Bilateral optic nerve edema presenting as initial manifestation of thyroid eye disease.The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?Electrophysiological Studies in Thyroid Associated Orbitopathy: A Systematic Review.Dysthyroid optic neuropathy: atypical initial presentation and persistent visual loss.Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy.[Management of moderate and severe dysthyroid orbitopathy: about 22 cases].Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report.Constitutively low expression of collagen XIII alpha 1 may help explain the vulnerability of the inferior rectus muscle to thyroid-associated ophthalmopathy.Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk.Changes in optical coherence tomography measurements after orbital wall decompression in dysthyroid optic neuropathy.Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.Surgical Treatment of Dysthyroid Optic Neuropathy: Long-Term Visual Outcomes with Comparison of 2-Wall versus 3-Wall Orbital Decompression.Thyroid-associated Ophthalmopathy.Reduction of orbital inflammation following decompression for thyroid-related orbitopathy.Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results
P2860
Q30413598-CA675C2A-0361-44F1-B13B-609510C0C778Q30461261-027DF728-DF83-47CF-B12F-25177851300BQ33363254-B6C78705-B934-4166-A685-B558F80BF8DDQ33802192-6424C802-C675-4926-838E-2F34A94A9ED8Q34200995-CD53842F-A9D6-434E-B69E-A5EB72B0B185Q35364814-FCFEA407-96C5-47FF-9973-D6651343A30DQ35886975-1413CB35-79AE-489D-B03E-177E7D050405Q36157117-DE2DC31C-2767-49C4-9063-F425B29C6907Q36738202-EB00BAAD-CF82-472F-AA8B-05725EC3D5D0Q36963786-DE7FDC92-7502-4C4B-8ACA-7FEF2881234BQ37147402-DC782598-670F-4AEC-A95F-9F6E5022F81CQ37236634-1D105363-C0C0-4569-BA02-5C04DF51D3C0Q37283088-E5917948-C483-40C3-B06A-054302903381Q37406589-65171AF3-398C-4021-B009-1C38B2FF13C9Q37533258-06C9CCBE-F4AF-42B5-AB34-F050B78F90BDQ37714114-DC6E8414-DC18-42F6-AD12-66FC5748BDD8Q37731429-666F0D41-CACB-4721-B8E6-CCF9A81CABB2Q37956160-02B6A9F5-E640-4AA1-A7D3-BD261A5FB343Q37963459-2FA5E4EE-F673-4FE5-A0A3-1434A31D8AC7Q38582072-9EB1D47C-A3F5-4E66-9E0F-15207606CCA7Q38692635-8FEDF515-C162-4435-9626-709BF5978CB9Q39169121-A835FB50-923F-4874-9491-CDF03DD7B861Q39303459-5784A730-E478-49EA-B661-C6E887668D46Q40095263-2B44310D-52C5-41DC-9A07-33AD523A7325Q42339087-1C44DC78-3DB3-4A56-94D2-0CD3E9D4AFFEQ42362243-ADFE3AD4-027A-4BE1-9687-562BA8794A0FQ43237703-8169605B-8948-4D4D-A6F4-B89DA60FC888Q44102313-2A9698CE-F573-406F-9DEC-43F2C604BC30Q46190198-E5F8D75D-D0F9-4F22-BB31-3EE8024924E7Q50156883-60BECFD2-894D-4121-B239-342600614D0AQ51540617-2B8628C9-1A3E-4FD4-AEDC-A0E4A67EEE81Q51856248-1006CE26-34FF-4D60-B5E9-EC6FCB8DF18DQ53081263-67DD2FBB-7341-40F4-8911-76004DA142CAQ53184848-3F2797FD-27D7-4CDE-802B-6CB07D602D92Q53557886-B7B7B5C8-58BC-4DCB-9747-FE129BA15ADBQ53743982-352CE5AA-295E-4270-A9D7-6B2333E9D092Q55390499-1CEF4171-205F-453F-A208-ABBE2CC3252AQ58767198-5EC96ACB-92E7-430E-8767-E7B3DF67A493
P2860
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@ast
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@en
type
label
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@ast
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@en
prefLabel
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@ast
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@en
P2093
P2860
P356
P1476
Clinical features of dysthyroi ...... ' Orbitopathy (EUGOGO) survey.
@en
P2093
A Iain Hullo
A Jane Dickinson
Aldo Pinchera
Carol Lane
Christopher Neoh
Claudio Marcocci
David McKeag
European Group on Graves' Orbitopathy (EUGOGO)
George Kahaly
Gerry Krassas
P2860
P304
P356
10.1136/BJO.2006.094607
P407
P577
2006-10-11T00:00:00Z